School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK.
School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK.
Mult Scler Relat Disord. 2019 Feb;28:276-282. doi: 10.1016/j.msard.2019.01.011. Epub 2019 Jan 3.
Fatigue is a complex and disabling symptom of Multiple Sclerosis (MS); however, there is conflicting evidence of the relationship between fatigue and clinical features of MS. Furthermore, few studies have considered these relationships specifically in a progressive MS population.
(1) estimate the prevalence of self-reported fatigue in people with MS; (2) evaluate the relationship between fatigue severity/impact and clinical features of MS; (3) compare the prevalence of fatigue, and the strength of relationship between fatigue severity/impact and clinical features of MS in progressive and non-progressive forms of MS.
An online survey was conducted to measure the severity (Fatigue Severity Scale (FSS)) and impact of self-reported fatigue (Modified Fatigue Impact Scale) in people with MS. The survey also contained questionnaires related to disability, quality of life, MS impact, anxiety and depression, cognition, and sleep quality.
412 people responded to the survey, of which 68.7% reported having fatigue (FSS ≥ 5). The prevalence of fatigue was significantly higher in participants with progressive MS (81%) in comparison to those with non-progressive forms of MS (64%, p = 0.01). Fatigue severity and impact were associated with quality of life, MS impact, anxiety, depression, cognition, and sleep quality in both progressive and non-progressive MS populations (p < 0.05). However, fatigue severity (r = 0.335) and impact (r = 0.391) were correlated with disability only in participants with non-progressive MS.
Fatigue was more prevalent amongst participants with progressive MS. In addition, higher fatigue severity and impact were associated with greater physical, cognitive, and psychological impairment, although the strength of association between these outcomes was generally similar regardless of the type of MS.
疲劳是多发性硬化症(MS)的一种复杂且使人丧失能力的症状;然而,疲劳与 MS 临床特征之间的关系存在相互矛盾的证据。此外,很少有研究专门在进展性 MS 人群中考虑这些关系。
(1)估计 MS 患者自我报告疲劳的患病率;(2)评估疲劳严重程度/影响与 MS 临床特征之间的关系;(3)比较进展性和非进展性 MS 形式中疲劳的患病率,以及疲劳严重程度/影响与 MS 临床特征之间的关系强度。
进行了一项在线调查,以衡量 MS 患者的疲劳严重程度(疲劳严重程度量表(FSS))和自我报告疲劳的影响(改良疲劳影响量表)。该调查还包含了与残疾、生活质量、MS 影响、焦虑和抑郁、认知和睡眠质量相关的问卷。
412 人回应了调查,其中 68.7%报告有疲劳(FSS≥5)。与非进展性 MS 患者(64%,p=0.01)相比,进展性 MS 患者的疲劳患病率明显更高(81%)。在进展性和非进展性 MS 人群中,疲劳严重程度和影响均与生活质量、MS 影响、焦虑、抑郁、认知和睡眠质量相关(p<0.05)。然而,仅在非进展性 MS 患者中,疲劳严重程度(r=0.335)和影响(r=0.391)与残疾相关。
进展性 MS 患者中疲劳更为普遍。此外,较高的疲劳严重程度和影响与更大的身体、认知和心理障碍相关,尽管这些结果之间的关联强度通常相似,无论 MS 的类型如何。